SCHEMBL13505312

SCHEMBL13505312

NC(=O)C(Cc1cccc(-c2ncccn2)c1)NC(=O)NCc1ccc(N)cc1

nearest known ligand 0.43

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ ALDH1A1 P00352 1/20 0.43
▸ ANPEP P15144 1/20 0.43
▸ PPID Q08752 3/20 0.43
▸ ATM Q13315 2/20 0.42
▸ ITGB3 P05106 1/20 0.42
▸ ITGAV P06756 1/20 0.42
▸ KLKB1 P03952 1/20 0.41
▸ L3MBTL1 Q9Y468 1/20 0.41
▸ HPGDS O60760 2/20 0.40
▸ NAMPT P43490 1/20 0.40
▸ LCK P06239 1/20 0.39
▸ CTSL P07711 1/20 0.39
▸ CTSB P07858 1/20 0.39
▸ CTSS P25774 1/20 0.39
▸ PSMB1 P20618 1/20 0.39
▸ PSMB5 P28074 1/20 0.39
▸ PSMB2 P49721 1/20 0.39
▸ ROCK2 O75116 1/20 0.39
▸ ROCK1 Q13464 1/20 0.39
▸ KDR P35968 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL13505431 0.81 ANPEP (0.63) ALDH1A1ANPEPPPIDATMKLKB1
SCHEMBL13505201 0.80 ANPEP (0.56) ALDH1A1ANPEPPPIDATMKLKB1
SCHEMBL12643956 0.79 PPID (0.45) ALDH1A1PPIDHPGDSROCK2ROCK1
SCHEMBL2052313 0.74 POLB (0.50) ALDH1A1ANPEPATMITGB3ITGAV
SCHEMBL13505315 0.74 PPARG (0.53) ALDH1A1ANPEPPPIDATMKLKB1
SCHEMBL13505761 0.72 PPID (0.52) ALDH1A1ANPEPPPIDATML3MBTL1
SCHEMBL22501724 0.72 HPGDS (0.50) HPGDSROCK2ROCK1
SCHEMBL12643839 0.72 ATM (0.65) ALDH1A1ANPEPPPIDATMKLKB1
SCHEMBL15832188 0.71 ADRB2 (0.35) ALDH1A1PPIDHPGDSNAMPTROCK1
SCHEMBL15832185 0.71 PPID (0.65) ALDH1A1ANPEPPPIDATMITGB3

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2516387-A2 NEW INHIBITORS OF CYCLOPHILINS AND USES THEREOF INSTITUT NATIONAL DE LA SANTE ET DE LA RECHERCHE MEDICALE (INSERM) (FR) 2012-10-31 — — EP disclosed
Send feedback